Daniel Nixdorf

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia.

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia.

Journal: Frontiers in immunology
Published: May 30, 2026

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

Journal: Leukemia
Published: December 10, 2025

TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

Journal: Journal for immunotherapy of cancer
Published: November 17, 2025

FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion.

FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion.

Journal: Blood advances
Published: August 22, 2025

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Journal: Blood advances
Published: August 22, 2025

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Journal: Blood advances
Published: August 22, 2025

RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress response.

RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress response.

Journal: Molecular cell
Published: March 03, 2025

STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer.

STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer.

Journal: Gastroenterology
Published: March 01, 2025

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia.

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia.

Journal: Blood
Published: September 13, 2024

Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.

Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.

Journal: Leukemia
Published: January 30, 2024

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.

Journal: Leukemia
Published: October 21, 2023

Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML.

Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML.

Journal: Leukemia
Published: January 15, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026